Page 2 - Stent Infinite News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2022 American Academy of Ophthalmology Annual Meeting

Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2022 American Academy of Ophthalmology Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesRostovskaya oblastJed lusthausMichele grayOluwatosinu smithMarka kontosInder paul singhFritzh hengererChris lewisThomasw samuelsonKatherins petersEric kimStevenr sarkisianAudreyr talleyJ bradley randlemanQin cui

5 top ophthalmic device innovations you need to know

Innovation finds its way into all areas of medtech, and ophthalmic treatments represent another burgeoning space.

Clareon monofocalAcuvue oasys maxAcuvue theravisionPrix galien internationalSight sciencesSight sciences nasdaqJohnson visionClinica scienceBrian pallClareon toricGalien international awardsStent infiniteClearside biomedical

Pulmonx (NASDAQ:LUNG) & Glaukos (NYSE:GKOS) Head to Head Analysis

Pulmonx (NASDAQ:LUNG – Get Rating) and Glaukos (NYSE:GKOS – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, dividends, risk, profitability, analyst recommendations and institutional ownership. Valuation & Earnings This table compares Pulmonx and Glaukos’ gross revenue, […]

United statesRedwood cityPulmonx company profile get ratingGlaukos company profile get ratingGlaukos corporationPulmonx corporationGet ratingGiven pulmonxCompany profileZephyr endobronchial valveChartis pulmonary assessment systemStratx lung analysis platformMiddle eastStent infiniteSan clementeNasdaq lung

Critical Survey: Integra LifeSciences (NASDAQ:IART) vs Glaukos (NYSE:GKOS)

Integra LifeSciences (NASDAQ:IART – Get Rating) and Glaukos (NYSE:GKOS – Get Rating) are both mid-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, valuation, profitability, analyst recommendations, earnings, institutional ownership and dividends. Analyst Ratings This is a summary of recent ratings and […]

United statesNew jerseyIntegra lifesciencesIntegra lifescienceAsia pacificGlaukos corporationIntegra lifesciences holdings corporationGet ratingGiven integra lifescienceLifesciences holdings corporationCodman specialty surgicalStent infiniteSan clementeNasdaq iartStock comparisonStock analysis